Axa SA (CS) Receives Average Rating of “Buy” from Analysts

Axa SA (EPA:CS) has been given an average recommendation of “Buy” by the fourteen research firms that are presently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is €26.21 ($30.47).

Several equities analysts have issued reports on the stock. Jefferies Financial Group set a €24.30 ($28.26) price target on shares of AXA and gave the stock a “buy” rating in a report on Wednesday, January 23rd. Barclays set a €24.00 ($27.91) price target on shares of AXA and gave the stock a “neutral” rating in a report on Monday, April 15th. JPMorgan Chase & Co. set a €28.20 ($32.79) price target on shares of AXA and gave the stock a “buy” rating in a report on Tuesday, January 29th. HSBC set a €29.70 ($34.53) price target on shares of AXA and gave the stock a “buy” rating in a report on Wednesday, January 23rd. Finally, Goldman Sachs Group set a €27.00 ($31.40) price target on shares of AXA and gave the stock a “buy” rating in a report on Friday, January 18th.

EPA:CS traded down €0.01 ($0.01) during trading hours on Friday, reaching €22.10 ($25.70). The company’s stock had a trading volume of 5,319,689 shares, compared to its average volume of 9,520,000. AXA has a 12 month low of €22.13 ($25.73) and a 12 month high of €27.69 ($32.20).

AXA Company Profile

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Featured Story: Different Types of Derivatives

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.